Also known as آسٹیوپوروسس مینجمنٹ
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Diabetologist
MBBS, FCPS (Medicine), Fellowship in Endocrinology
Internal Medicine Specialist
MBBS, FCPS (Medicine)
General Physician
M.B.B.S , M.C.P.S (Family Medicine)
Diabetologist
M.B.B.S, F.C.P.S. (Medicine) , MD (USA)
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
MBBS, MD, MCPS
Diabetologist
MBBS, FRCP (Ed.), FRCP (Glasg.), MRCP (UK), FACP (USA), FACC (USA), FASIM (USA), M.D
Diabetologist
MBBS, FRCP (Ed.), FRCP (Glasg.), MRCP (UK), FACP (USA), FACC (USA), FASIM (USA), M.D
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCP (UK), Fellow Rheumatology
Pulmonologist
MBBS, MRCP (UK), F.R.C.P
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures